[ June 26, 2008 ]
New York, USA
DNDi’s First Stakeholders’ meeting took place on 26th June in New York and brought together 150 scientists, researchers, academics, and global health leaders from 25 countries to discuss how international research partnerships can best develop and deliver new lifesaving drugs for neglected diseases.
[ June 26, 2008 ]
[ April 2008 ]
Rio de Janeiro, Brazil
Farmanguinhos/Fiocruz and DNDi launched ASMQ, the new fixed-dose combination of artesunate (AS) and mefloquine (MQ), now registered in Brazil. Developed and delivered by a worldwide collaboration of public partners, ASMQ will soon be available throughout Latin American and Southeast Asia.
[ February 2008 ]
The 10th Leishmaniasis East Africa Platform (LEAP) meeting took place in Khartoum, Sudan. A solid clinical trial network is being built, thanks to the serious commitment of all members. Capacity building is still ongoing, with one site in Kenya to be built and another in Uganda to be strengthened. In May 2008, DNDi and its partners inaugurated a new treatment centre in Gondar, Ethiopia, with a 24 bed capacity.
[ November 2007 ]
Sanofi-aventis and DNDi held a symposium on the implementation of a new artemisinin combination therapy (ACT) in African endemic countries. Over 120 attendees from NGOs, academia, and the pharmaceutical sector heard presentations by FACT project partners on ASAQ and ASMQ. In addition, DNDi also presented the ethical considerations of malaria field studies, and screening of natural products against infectious disease pathogens.
[ September 2007 ]
DNDi and the Leishmaniasis East Africa Platform (LEAP) organised a scientific symposium on visceral leishmaniasis (VL): “A step together in the right direction” at the centenary meeting of the Royal Society of Tropical Medicine and Hygiene (RSTMH), in London. More than 120 scientists attended the meeting.
[ June 2007 ]
The PAN4ND Annual Meeting was held at Shanghai Institute Materia Medica, 4th-6th June 2007, and included three sessions: The Annual Meeting of the Pan-Asian Screening Network; the Natural Product Working Group, and the Natural Product Symposium.
[ May 2007 ]
Amsterdam, The Netherlands
DNDi, in two presentations, discussed how Product Development Partnerships could deliver innovative treatments to patients, and the sanofi-aventis / DNDi Partnership against malaria, at the 5th ECTMIH from 24 to 28 May in Amsterdam.
[ March 2007 ]
Sanofi-aventis and DNDi launched ASAQ, the new fixed-dose combination of artesunate (AS) and amodiaquine (AQ), which is now available in 21 countries throughout sub-Saharan Africa (June 08). ASAQ, the first drug developed by DNDi, is an innovative product to treat malaria that is adapted to the needs of patients of all ages, simple to use, accessible as a non patented drug, and available at an affordable price.
DNDi participated in two symposiums at the ASTMH in Atlanta.
[ September 2006 ]
Over 200 African scientists from 34 countries met in Nairobi, Kenya, 19-23 September at an international conference organised by the Drugs for Neglected Diseases initiative (DNDi), to explore developing greater regional research partnerships to combat the most neglected diseases, such as sleeping sickness, kala azar and malaria.
6-11 August 2006 ]
11th International Congress of Parasitology.
[17 June 2006]
[8 February 2006
European Parliament, Brussels, Belgium
[12-16 December 2005
Washington DC, USA
The 54th annual American Society of Tropical Medicine and Hygiene (ASTMH) Conference.
[11 September 2005 to 15 September 2005]
[05 April 2005]
Rio de Janeiro , Brazil
[18 January 2005
[07 November 2004 to 11 November 2004
Miami, United States
The 53rd annual meeting of the American Society of Tropical Medicine and Hygiene.
[7-8 October 2004]
The 25th African Health Sciences Congress.
[27 July 2004]
Workshop organized to discuss the collaboration of international initiatives involved in interventions for Poverty Related Diseases.